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 This meta-analysis focuses on anxiety and depressive disorders among youth with ID 
 Pooled prevalence of anxiety and depressive disorders were 5.4% and 2.8%  
 Pooled prevalence for subtypes of anxiety disorders ranged from 0.2%-11.5% 
 Pooled prevalence for subtypes of depressive disorders ranged from 2.5%-3.4% 
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Abstract 
Background. The purpose of this meta-analytic study was to determine the pooled prevalence estimates 
of anxiety and depressive disorders among children and adolescents with intellectual disabilities (ID) and 
to assess the extent to which these pooled prevalence rates differed according to studies’ characteristics.  
Method. A systematic literature search was performed in nine databases and 20 studies, published 
between 1975 and 2015, met the inclusion criteria.  
Results. The resulting pooled prevalence estimates of combined subtypes of anxiety and depressive 
disorders were respectively (a) 5.4% and 2.8% across samples; (b) 1.2% and 0.03% among children; and 
(c) 7.9% and 1.4% among adolescents. Pooled prevalence estimates for specific subtypes of anxiety 
disorders ranged from (a) 0.2% to 11.5% across samples; (b) 0.7% to 17.6% among children; and (c) 0.6% 
to 19.8% among adolescents. Pooled prevalence estimates of dysthymic disorder and major depressive 
disorder were respectively (a) 3.4% and 2.5% across samples; (b) 2.1% and 3.2% among children; and (c) 
6.9% and 5.7% among adolescents. Finally, subgroup analyses showed significant variations in the pooled 
prevalence estimates of combined subtypes of anxiety disorders, obsessive-compulsive disorder, and 
generalized anxiety disorder; and combined subtypes of depressive disorders.   
Limitations. The present findings of this meta-analysis should be interpreted with caution given several 
limitations related to the characteristics of the populations, diagnosis method and sampling method.  
Conclusion. Findings provide recommendations for future studies investigating psychological disorders 
among youth with ID, as well as how clinicians and policy makers can improve diagnostic practices and 
support for youth with ID. 
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1. Introduction 
The last two decades have witnessed a growing research interest in the prevalence of 
psychological disorders among youth with intellectual disabilities (ID) and their results have been 
summarized in a few systematic reviews1 (e.g., Einfeld, Ellis, & Emerson, 2011; Hudson & Chan, 2002; 
Oeseburg, Dijkstra, Groothoff, Reijneveld, & Jansen, 2011; Whitaker & Read, 2006). Overall, these 
reviews reveal that a large proportion of youth with ID present with at least one psychological disorder, 
although exact prevalence rates remain poorly documented (Oeseburg et al., 2011). For example, Einfeld 
et al. (2011), and Whitaker and Read (2006) reported that between 30%-50% of children and 24%-54% of 
adolescents with ID experience at least one psychological disorder. Einfeld et al. (2011) further showed 
that this rate was 2.8 to 4.5 times greater for youth with ID than the rates obtained among typically 
developing (TD) youth.  
Although the proportion of youth with ID experiencing psychological disorders, in general, has 
been addressed within the literature, reviews focusing on prevalence estimated for specific psychological 
disorders in this population remain limited. In particular, no systematic review or meta-analysis have yet 
provided a summary of findings, or analysis of findings, from prevalence studies focusing specifically on 
depressive disorders among youth with ID or reported pooled prevalence estimates of depressive 
disorders among this population. Additionally, although Reardon, Gray, and Melvin (2015) recently 
summarized studies on the prevalence of anxiety disorders among youth with ID, their initial effort 
presents several shortcomings that need to be addressed. First, the pooled prevalence of specific and 
combined subtypes of anxiety disorders have not been estimated, notably those of anxiety-related 
disorders (as defined in previous diagnostic classifications), such as obsessive-compulsive or 
posttraumatic stress disorders. Second, Reardon et al. (2015) did not examine whether the prevalence 
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characteristics, such as age (children vs. adolescents-young adults), sex (boys vs. girls), ID level (e.g., mild 
vs. moderate or severe), and geographic location (e.g., North America vs. Europe). Third, Reardon et al. 
(2015) did not investigate the potential moderating role played by the specific source of information 
used to assess the presence of anxiety disorders (e.g., medical records, interview, clinical judgment, or 
multiple assessments).  
The specific focus of the present article on anxiety and depressive disorders is highly relevant. 
Firstly, longitudinal studies with TD youth have established that anxiety and depressive disorders in 
childhood and adolescence serve as significant predictors of future mood disorders (Roza, Hofstra, van 
der Ende, & Verhulst, 2003) and major depression in adulthood (Reinherz, Paradis, Giaconia, Stashwick, 
& Fitzmaurice, 2003). Given their role as precursors for adulthood wellbeing, research must seek to 
determine the specific prevalence of anxiety and depressive disorders for youth with ID and whether 
these disorders are prevalent at higher or lower levels than in TD youth in order to guide the 
preventative work of policy makers, researchers, and practitioners. Secondly, although previous 
systematic reviews investigating a wider range of psychological disorders in general are helpful (e.g. 
Einfeld et al., 2011; Oeseburg et al., 2011), a specific focus on anxiety and depression affords a more 
thorough and nuanced analysis of both the potential sample and study characteristics that may be 
driving disputed prevalence rates for youth with ID. Providing precise and up to date information is 
critical to inform future research and practice in the identification and management of anxiety and 
depression disorders for youth with ID.  
With the present systematic review and meta-analysis we intend to address the shortcomings of 
previous research. More specifically, the first objective was to estimate the pooled prevalence rates of 
anxiety and depressive disorders (specific and combined subtypes) for all of the samples in this review, 
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whether the pooled prevalence rates of anxiety and depressive disorders differ as a function of specific 
characteristics of the studies. 
2. Method 
This systematic review and meta-analysis was performed following guidelines from the Preferred 
Reporting Items for Systematic reviews and Meta-Analyses statement (PRISMA; Liberati et al., 2009) and 
the Meta-Analysis Of Observational Studies in Epidemiology statement (MOOSE; Stroup et al., 2000).  
2.1 Information Sources and Search Strategy 
Potentially relevant studies were identified through a systematic and simultaneous electronic 
search in Academic Search Complete, CINAHL Plus with Full-Text, Education Sources, ERIC, Medline with 
Full-Text, Psychology and Behavioral Sciences Collection, and SocINDEX via the EBSCO database. In 
addition, a systematic electronic search was conducted separately in the PsycARTICLES (including 
PsycINFO) and Scopus databases. No year restriction was imposed in the electronic search and the last 
updated search was performed on the 26th of November 2016. Studies were identified in the 
aforementioned databases using the following three groups of search terms: (1) “intellectual* dis*” OR 
“mental* retard*” OR “developmental dis*” OR “developmental del*”; AND (2) anxiet* OR anxious OR 
depress* OR “affect* dis*”; AND (3) child* OR adolescen* OR student* OR youth* OR paediatric* OR 
pediatric*. The search strategy used in Scopus database is presented in the online supplement (see the 
section S1). More precisely, these groups were combined and researched in the title, abstract and 
keywords of the studies published by the journals indexed in the searched databases. Finally, a manual 
search was also conducted in: (a) the reference lists of the articles included in the meta-analysis and in 
the manuscripts citing these articles; and (b) in previous literature reviews on anxiety (Reardon et al., 
2015) and psychological disorders (Borthwick-Duffy, 1994; Einfeld et al., 2011; Hemmings et al., 2013; 
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with ID. 
2.2 Inclusion Criteria 
Only the studies meeting the following inclusion criteria were included in the meta-analysis. First, 
participants had to present mild, moderate, severe, or profound ID2 (or a developmental delay) of known 
(i.e., autism spectrum disorder, Down syndrome, Fragile X syndrome, Williams syndrome, Prader-Willi, 
etc.) or unknown etiology. However, studies exclusively focusing on participants with ID of a specific 
known etiology were not included. The rationale for excluding these studies is that: (1) we could not be 
confident that all studies limited to these subpopulations would be identified as they often do not focus 
on their ID levels as does the current meta-analysis; (2) the prevalence of anxiety or depression disorders 
has already been quantified for these subpopulations (e.g., Royston, Howlin, Waite, & Oliver, 2017; van 
Steensel, Bögels, & Peerin, 2011); and (3) the phenotype of people from these subpopulations can 
heighten their vulnerability to anxiety or depressive disorders, and thus bias prevalence estimates 
associated with more generic forms of ID (e.g., Royston et al., 2017; van Steensel et al., 2011). Finally, 
studies which included a range of disabilities within the sample were considered to be eligible if the data 
on the relevant outcomes were available for participants with ID. 
Second, the participants with ID included in the studies had to be infants (0-3 years), children (4-11 
years), or adolescents-young adults (12-22 years). Mixed samples of adolescents and adults with ID were 
included if the data on the relevant outcomes were presented for the participants aged 22 years and 
lower. Studies exclusively focusing on samples of adults with ID were excluded. 
Third, studies were considered to be eligible only if one of their main objective was to determine 
the prevalence of anxiety (e.g., combined subtypes of anxiety disorder3, agoraphobia, generalized 
anxiety disorder, obsessive-compulsive disorder) and/or depressive disorders (i.e., combined subtypes of 
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studies including participants with a diagnosed anxiety disorder and/or depressive disorder aiming to 
compare their clinical features with those from non-clinical participants, or to validate screening 
instruments, were not included. In addition, when the same sample (or a part of a sample) was used in 
several publications, the most recent or the largest sample was included. In this situation, outcomes of 
interest not reported in the selected publication were also included from the other publication.  
Fourth, for studies to be included, anxiety and/or depressive disorders had to be diagnosed by 
qualified professionals (e.g., physician, psychiatrist, psychologist, pediatrician) and/or obtained by the 
research team through a structured diagnostic interview. Therefore, studies focusing on specific 
symptoms or using screening cut-off scores (e.g., Child Behavior Checklist, Developmental Behavior 
Checklist) were excluded. Indeed, the focus here was on the prevalence of psychiatric diagnoses, rather 
than on either the clinical severity of symptoms or the presence of participants “at risk” of meeting 
clinical criteria diagnoses. In addition, the diagnosis performed by qualified professionals requires a 
discussion with the target participant and/or informant as well as an assessment of the severity and 
discomfort associated with the assessed symptoms, which is typically lacking as part of screening 
severity procedures relying on participant and/or informant reports.  
Finally, we only included studies relying on cohort (only the first or initial measure was 
considered), cross-sectional or case-control design written in English and published or in-press in a peer-
reviewed journal. Case studies, book chapters, conference proceedings, and non-original studies (i.e., 
comments, reviews, theoretical papers) were excluded.  
2.3 Selection of the Relevant Studies  
As recommended by the PRISMA Statement (Liberati et al., 2009), the eligibility of the relevant 
studies was determined based on the examination of the titles-abstracts and full texts. First, the 
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second, and last). Then, the full texts of the studies selected based on their titles-abstracts were also 
independently screened by the same three authors to assess their eligibility. At each step, discrepancies 
between authors were resolved by discussion until an agreement was reached.  
2.4 Data Extraction  
The same three authors independently extracted the information and data presented in the full 
text articles of studies included in the meta-analysis. The following information was extracted: (a) 
location (country); (b) design (cohort, cross-sectional, case control); (c) recruitment setting (e.g., service 
agencies, special school, child psychiatric unit); (d) type of samples (children, adolescents, mixed); (e) 
characteristics of samples with ID (i.e., sample size, percentage of boys, age range, and ID level); (f) 
presence/absence (yes/no) and sample size of TD participants; (g) diagnostic information (i.e., informant, 
method, and criteria); (h) types of anxiety disorders (e.g., combined subtypes, agoraphobia without 
panic disorder, generalized anxiety disorder, any anxiety disorders); (i) types of depressive disorders 
(e.g., combined subtypes, depressive disorders, dysthymic disorder, major depressive disorder); (j) 
prevalence estimates (i.e., the percentage and the sample size or the frequencies) of anxiety and 
depressive disorders. The information and the data extracted were reviewed and discrepancies were 
resolved by discussion. 
2.5 Quality Assessment of the Studies Included in the Meta-Analysis  
An adapted version of the Methodological evaluation of Observational REsearch (MORE) 
checklist for observational studies of incidence or prevalence of chronic diseases was used to assess the 
quality of reporting of studies (Shamliyan et al., 2013). The scoring regarding the external (i.e., sampling 
method, estimation of sampling bias, sampling bias in the analysis) and internal validity (i.e., source, 
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authors. Their results were then reviewed by the two authors, and remaining disagreements were 
resolved by the second author.  
2.6 Statistical Analysis 
All the analyses were performed using the version 2.2.064 of the Comprehensive Meta-Analysis 
(CMA) software developed by Borenstein, Hedges, Higgins, and Rothstein (2005). Given the 
heterogeneity of the studies included in the meta-analysis (participants’ characteristics, diagnostic 
method, sample size, etc.), a random effects model was used to estimate the pooled or weighted 
prevalence of anxiety and depressive disorders. First, the pooled or weighted prevalence rates of anxiety 
and depressive disorders were estimated including all the relevant studies. Second, the pooled or 
weighted prevalence rates of anxiety and depressive disorders were separately estimated for studies 
including children or adolescents. The forest plots of these pooled prevalence estimates were graphed 
using the Microsoft Excel spreadsheet developed by Neyeloff, Fuchs, and Moreira (2012). The 
heterogeneity of the pooled prevalence estimates was examined using Cochran’s (1950) Q test and 
Higgins, Thompson, Deeks, and Altman’s (2003) I² statistic. Finally, several statistical tests provided by 
the CMA software were used (Begg and Mazundar’s rank correlation test, 1994; Duval and Tweedie’s 
“trim and fill” test, 2000; Egger’s test of the intercept, 1997) to assess potential publication bias in the 
pooled prevalence estimates of anxiety and depressive disorders. 
Moderation analyses were examined using a mixed effect model. We performed a series of pre-
specified subgroup analyses for the four following variables: (a) ID level (borderline, mild, moderate, 
severe, profound, unspecified); (b) geographic regions as defined by the World Health Organization 
(Europe, North America, South America); (c) diagnostic method (interview, medical records, multiple 
assessments); (d) diagnostic criteria (the diagnostic and statistical manual of mental disorders [DSM]: 
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international statistical classification of diseases and related health problems [ICD-10]); and (e) 
informant (e.g., caregiver, caregiver and parents, parents, parents and youth). No moderation analyses 
were performed when only one study was available in a pre-specified subgroup.  
3. Results 
3.1 Study Selection 
The electronic and manual search identified a total of 10,671 relevant articles, which fell to 7,786 
when duplicates were removed. A total of 7,673 articles were excluded based on the analysis of their 
title and abstract. Then, the full text of the remaining 113 articles (see section S2 in the online 
supplements for the full references of these studies) were assessed and 92 were excluded for reasons 
presented in Figure 1. Therefore 21 studies, detailed in Tables 1 and 2 and published between 1975 and 
2015, met the inclusion criteria and were included in this meta-analysis. 
3.2 Study Characteristics 
Design and Sample Characteristics. As illustrated in Table 1, most of the studies were conducted 
in North America (n = 9) and Europe (n = 10). More than two third of the studies (15/21) had a cross-
sectional design, and only four had included a TD sample for comparative analyses. Overall, a total of 
57,971 youth with ID (M = 2,760; range = 30 to 43,738) participated in these studies, and 12/21 studies 
(57.1%) recruited participants from service agencies or schools. Additionally, the majority of studies 
(13/21, 61.9%) included participants with borderline-mild to severe-profound ID. In addition, 3/21 
studies (14.3%) focused on children (4–11 years), 5/21 (23.8%) on adolescents-young adults (12–21 
years), and 13 of the 21 (61.9%) focused on mixed-age sample (e.g., infants to adolescents-young adults, 
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Diagnostic Information. As presented in Table 2, the information used to diagnose anxiety or 
depressive disorders was mostly obtained from multiple respondents (n = 6; i.e., parents, youth, and/or 
caregivers) or from parents only (n = 7). Additionally, diagnoses have been obtained using multiple 
assessments (33.3%), medical records (33.3%), and interviews (33.3%). Finally, these diagnoses were 
mostly determined based on DSM criteria (57.1%), followed by the ICD-10 criteria (33.3%).  
Types of Anxiety and Depressive Disorders. As illustrated in Table 2, 19/21 (90.5%) studies 
reported the prevalence of anxiety disorders, and one third focused on diagnostic subtypes such as 
generalized anxiety disorder, obsessive-compulsive disorder, posttraumatic stress disorder, separation 
anxiety disorder, etc. Additionally, 15/21 studies (71.4%) reported the prevalence of depressive 
disorders, and one third focused on diagnostic subtypes such as dysthymic disorder and major 
depressive disorder. 
3.3 Prevalence Estimates: Anxiety Disorders 
All Samples. Prevalence estimates of combined subtypes of anxiety disorders were reported in 
18 studies (see Figure 2a for the forest plot). Prevalence estimates are reported in Table 3. Across these 
studies, the pooled prevalence estimate was 5.4% (95% CI = 2.5–11.5), with a very high level of 
heterogeneity. No evidence of publication bias was noted by most of the tests, except for the Duvall and 
Tweedie’s trim and fill test which revealed that one study was missing on the left of the funnel plot. 
When this study was imputed to obtain a symmetrical funnel plot, the pooled prevalence estimate 
became 4.7% (95% CI = 2.1–10). 
Specific subtypes. Ten specific subtypes of anxiety disorders were reported in the studies (see 
Figures S1a-f and Table S1 in the online supplements for forest plots and references). Their prevalence 
estimates ranged from 0.2% for panic disorder with agoraphobia to 11.5% for specific phobia (Table 3). 












Anxiety, Depression, and Intellectual Disabilities 15 
for which the Duvall and Tweedie’s trim and fill revealed that one study was missing. The imputation of 
this missing study gave a pooled prevalence estimate of 10.2% (95% CI = 4.1–23.2) for specific phobia. 
Children Samples. Prevalence estimates of combined subtypes of anxiety disorders among 
children were reported in three studies (Figure 2b). The pooled prevalence estimate (Table 3) was 1.2% 
(95% CI = 0–49.1), with a very high percentage of heterogeneity. The Duvall and Tweedie’s trim and fill 
revealed that two studies were missing. The imputation of these missing studies gave a pooled 
prevalence estimate of 0.1% (95% CI = 0–5.5). 
Specific subtypes. Only one study (Table S1) reported prevalence estimates for three specific 
subtypes of anxiety disorders (generalized anxiety disorders, separation anxiety disorder, and social 
phobia). These prevalence estimates range from 0.7% for generalized anxiety disorders to 18% for 
separation anxiety disorder (Table 3).  
Adolescent Samples. Prevalence estimates of combined subtypes of anxiety disorders were 
reported in five studies (Figure 2c). The pooled prevalence estimate was 7.9% (95% CI = 0.6–54.6), with a 
very high percentage of heterogeneity (Table 3). The Duvall and Tweedie’s trim and fill revealed that 
three studies were missing to obtain a symmetrical funnel plot. The imputation of these missing studies 
gave a pooled prevalence estimate of 0.5% (95% CI = 0–7.8). 
Specific subtypes. Seven specific subtypes of anxiety disorders were reported in the studies 
(Table S1). In these studies, prevalence estimates ranged from 0.6% for panic disorder to 19.8% for 
specific phobia (Table 3). Given the very few number of studies per anxiety subtype, no publication bias 
analyses were performed. 
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All Samples. Prevalence estimates of combined subtypes of depressive disorders were reported 
in 10 studies (Figure 3a). Prevalence estimates are reported in Table 4. Across these studies, the pooled 
prevalence estimate was 2.8% (95% CI = 1.1–6.7), with a very high percentage of heterogeneity. No 
evidence of publication bias was noted by most of the tests, except for the Duvall and Tweedie’s trim 
and fill test revealing that three studies were missing. When these studies were imputed, the pooled 
prevalence estimate became 1.6% (95% CI = 0.6–3.7). 
Specific subtypes. Two specific subtypes of depressive disorders were reported in the selected 
studies (see Figures S2a-b and Table S2 in the online supplements for forest plots and references). 
Pooled prevalence estimates were 3.4% for dysthymic disorder and 2.5% for major depressive disorder 
(Table 4). No publication bias was found. 
Children Samples. Combined subtypes of depressive disorders were considered in only one 
study (Table S2), which reported a prevalence estimate of 0.03% (95% CI = 0.0–0.1). 
Specific subtypes. Two specific subtypes of depressive disorders were considered in the studies 
(Table S2), and their pooled prevalence estimates were 2.1% for dysthymic disorder and 3.2% for major 
depressive disorder. Given the very few number of studies per depressive subtype, no publication bias 
analyses were performed. 
Adolescent Samples. Prevalence estimates of combined subtypes of depressive disorders were 
reported in three studies (Figure 3b). The pooled prevalence estimate was 1.4% (95% CI = 0.4–5.1), with 
a very high percentage of heterogeneity (Table 4). The Duvall and Tweedie’s trim and fill test revealed 
that two studies were missing. The imputation of these studies provided a pooled prevalence estimate of 
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Specific subtypes. Two specific subtypes of depressive disorders were considered in the studies 
(Table S2), and their pooled prevalence estimates were 6.9% for dysthymic disorder and 5.8% for major 
depressive disorder (Table 4). Given the very few number of studies per depressive subtype, no 
publication bias analyses were performed. 
3.5 Moderation Analyses 
Results from the moderation analyses are detailed in Tables S3-S6 in the online supplements. 
Given the low number of studies comprising samples of children and adolescents only, the analyses were 
only performed across all samples (children, adolescents, and mixed), rather than on age-specific 
samples. 
Anxiety Disorders. The results showed significant differences in pooled prevalence estimates of 
combined subtypes of anxiety disorders and obsessive-compulsive disorder according to the diagnostic 
method that was used (Table S3). Pairwise comparisons showed that the prevalence estimate of 
combined subtypes of anxiety disorders was significantly higher when participants were diagnosed by 
interview (22.5%) than by multiple assessments (5.3%) or medical records (1.9%). In addition, the pooled 
prevalence estimate of obsessive-compulsive disorder among youth with ID was significantly higher 
when participants were diagnosed by interview (7.3%) than by multiple assessments (0.4%).  
The results also showed significant differences in the pooled prevalence estimates of combined 
subtypes of anxiety disorders, obsessive-compulsive disorder, and generalized anxiety disorder as a 
function of the diagnostic criteria that were used (Table S3). Pairwise comparisons showed higher rates 
of combined subtypes of anxiety disorders when participants were diagnosed using the DSM-IV (21.4%) 
rather than the DSM-III (6.5%), ICD-10 (4.4%), or DSM-III-R (0.6%) criteria. The prevalence of obsessive-
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rather than the ICD-10 (0.4%) criteria. However, prevalence of generalized anxiety disorder was higher 
when participants were diagnosed using the ICD-10 (2.3%) rather than DSM-IV (0.3%) criteria. 
Finally, results showed a significant difference in pooled prevalence estimates of combined 
subtypes of anxiety disorders according to the informant (Table S3). More specifically, rates of combined 
subtypes of anxiety disorders were higher when the informant was the parents (15%) rather than the 
parents and youth (4.4%). Finally, no significant variations were found as a function of ID level and 
geographic location. 
Depressive Disorders. The results showed significant differences in prevalence of combined 
subtypes of depressive disorders according to the ID level of the participants (Table S5). Pairwise 
comparisons showed that prevalence estimates were significantly higher among youth with a borderline 
ID (17.1%) than among those with a moderate (3.5%), severe (2.6%), or unspecified ID (3.4%). No 
significant variations were found as a function of geographic location, diagnostic method and criteria, 
and informant. 
3.6 Quality Assessment of the Studies 
Table 5 reports the quality ratings of studies based on the adapted MORE's criteria (Shamliyan et al., 
2013). Only six studies (6/21, 28.6%) used a population-based sample raising concerns about the 
representativeness of the results obtained in terms of prevalence. Moreover, most of the studies (17/21, 
80.9%) failed to report the response rate (meaning that we cannot estimate the sampling bias) and the 
subject flow (20/21, 95.2%). However, nine studies performed subgroup analyses (mostly according to 
age and/or sex subgroups).  
Regarding the internal validity, only seven studies (7/21, 33.3%) reported and justified the reference 
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the studies reported information about the source of the measure (15/21, 71.4%) and whether the 
outcomes were measured for the purpose of the study (11/21, 52.4%). Finally, most of the studies did 
not document the validity and reliability of the instruments used to measure anxiety and depression 
(16/21, 76.2%), nor did they report information about the precision of estimate (17/21, 80.9%) or 
adjusted estimates (19/21, 90.5%). 
4. Discussion 
4.1 Prevalence Estimates of Anxiety and Depressive Disorders 
The first objective of this review and meta-analysis was to provide a synthesis of the empirical 
studies examining the prevalence of anxiety and depressive disorders among children and adolescents 
with ID, and then to estimate the pooled or weighted prevalence of these disorders among these 
populations combined and separately. 
Anxiety Disorders. The findings revealed a pooled prevalence estimate for combined subtypes of 
anxiety disorders of 5.4% across samples, with a large heterogeneity (ranging from 0.1% to 40%). This 
prevalence estimate is slightly lower than those found in recent meta-analyses of samples of TD youth, 
where the pooled prevalence of combined subtypes of anxiety disorders were 6% (Baxter et al., 2013), 
6.5% (Polanczyk et al., 2015), and 10.2% (Costello et al., 2011). In addition, the current meta-analysis 
showed that prevalence of combined subtypes of anxiety disorders were six times more important 
among adolescents with ID (7.9%; ranging from 0.2% to 40%) than among children (1.2%; 0.1% to 
17.6%). This result is not in line with Costello et al.’s (2011) meta-analysis that found comparable 
prevalence rates in TD children (12%) and adolescents (11%). Finally, 10 specific subtypes of anxiety 
disorders were examined in the reviewed studies. Findings showed that (a) specific phobia (11.5%) was 
highly prevalent across all samples; (b) children with ID suffer more frequently from separation anxiety 
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obsessive-compulsive disorder (12%), and social phobia (8%). These findings are consistent with those 
found by Costello et al. (2011) among TD youth. 
Depressive Disorders. Our results revealed a pooled prevalence estimate for combined subtypes 
of depressive disorders of 2.8% (range = 0.1%-14%) across samples. This prevalence estimate matches 
the 2.6% found by Polanczyk et al. (2015) in their meta-analysis among TD youth. Additionally, even if 
these prevalence estimates remain low, it is interesting to note that combined subtypes of depressive 
disorders are more frequent in adolescents with ID (1.4%; range = 0.5%-2.7%) than children (0.3%). This 
greater risk of depressive disorders for adolescents is well documented among TD youth (e.g., Birmaher 
et al., 1996). More specifically, pooled prevalence estimates were higher for major depressive disorders 
(3.2%) than for dysthymic disorders (2.1%) in children; while dysthymic disorders (6.9%) were more 
frequent than major depressive disorders (5.8%) in adolescents. These prevalence rates are consistent 
with those found in previous reviews and meta-analyses conducted among samples of TD youth 
(Birmaher et al., 1996; Merikangas, Nakamura, & Kessler, 2009; Polanczyk et al., 2015).  
4.2 Moderators 
The second objective of the current meta-analysis was to examine the source of heterogeneity in 
the reported prevalence of anxiety and depressive disorders. Due to the low number of studies including 
children or adolescents, the moderation analyses could not be conducted separately as a function of age. 
Anxiety Disorders. Our findings suggest that prevalence of combined subtypes of anxiety 
disorders and obsessive-compulsive disorders are higher when the diagnosis is obtained by an interview 
rather than by multiple assessments. This result may be explained by the fact that a single method of 
data collection may be not sufficiently specific to screen for these types of psychological disorders 
among youth with ID. The complexity of the diagnosis of anxiety disorders among this population, which 
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to rely on a multiple or multidimensional assessment (Pruijssers, van Meijel, & van Achterberg, 2011; 
Sullivan et al., 2006, 2011). Alternatively, it may also be hypothesized that an interview schedule is a 
more sensitive, and thus more appropriate, tool to identify psychological disorders among youth with ID 
where other means may be unable to do so. 
In addition, higher prevalence of combined subtypes of anxiety disorders and obsessive-
compulsive disorders (except for generalized anxiety disorder) were observed when the diagnosis was 
made using the DSM-IV or DSM-IV-TR criteria compared to the DSM-II, DSM-III, DSM-III-R, or the ICD-10 
criteria. The results also showed that higher prevalence of combined subtypes of anxiety disorders were 
observed when parents were the only source of information rather than when both parents and youth 
were. This result may be explained by the fact that the parents' own distress may affect their report of 
their child’s anxiety; or alternatively by the possibility that current diagnostic tools may be unable to 
correctly identify high levels of psychological disorders when reported by youth with ID themselves. The 
inclusion of youth as an additional source of information may certainly help the clinician to refine his/her 
decision. However, the process of obtaining these insights must be shown to be reliable for this 
population. Finally, no significant variations were found as a function of ID level, and geographic location. 
Depressive Disorders. The findings showed that youth with borderline ID were significantly more 
at risk of having a depressive disorder than those with a moderate, severe, or unspecified ID. This may be 
due to the fact that the identification of depressive symptoms among youth with lower levels of 
intellectual functioning represents a challenging issue as a result of their limited abilities to communicate 
about their internal states and the inappropriateness of standard diagnostic criteria (Bailey & Andrews, 
2003; Barnhill, 2008; Morin et al., 2010; Ross & Oliver, 2003; Smiley & Cooper, 2003). Therefore, some 
symptoms may not be recognized or identified correctly among youth with ID (Morin et al., 2010). To 
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adapted diagnostic criteria for use with adults with learning disabilities/mental retardation (DC-LD; Royal 
College of Psychiatrists, 2001). Additionally, other scholars (for reviews see: Janowsky & Davis, 2005; 
Morin et al., 2010) have also provided standard reference for the diagnosis of psychological disorders in 
persons with ID (Fletcher, Loschen, Stavrakaki, & First, 2007) or modified criteria for research (Clarke & 
Gomez, 1999). However, none of the studies included in the present review have used these criteria 
among youth with ID.  
The findings of the current meta-analysis suggest that there is no substantial difference in the 
prevalence of anxiety and depressive disorders for youth with ID when compared to TD youth. This 
finding, however, may be attributable to the low quality of the studies reviewed. Methodological deficits 
in diagnoses impact on research that seeks to depict prevalence rates and thus inform practice. It is 
hypothesized that diagnostic overshadowing (Masi, 1998; Reiss, 2000) occurs whereby symptoms of 
psychological disorders do not result in a diagnosis but rather are attributed to the diagnosis of ID. 
Additionally, it is proposed that current diagnostic procedures may be ill-equipped to identify 
psychological disorders in youth with ID as their symptoms may not align with current diagnostic criteria 
for TD youth (Cooper, Melville, & Einfeld, 2003; Whitaker & Read, 2006). 
4.3 Limitations and Directions for Future Studies 
The present findings of this meta-analysis should also be interpreted with caution given several 
limitations. First, most of studies were conducted in North America or in Europe. Therefore, the 
magnitude of anxiety and depressive disorders in the Western Pacific region, African region, South-East 
Asia region, and Eastern Mediterranean region is underreported. Additionally, only a minority of studies 
have examined the prevalence according to sex, age, ID level, and additional diagnoses (autism spectrum 
disorder or genetic syndromes such as Down syndrome, Fragile X, etc.). Unlike the current meta-analysis, 
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additional diagnoses as a single combined group for purposes of analyses. Unlike the current meta-
analysis, these reviews have typically found a higher prevalence of psychological disorders for this group 
compared to TD youth (e.g., Einfeld et al., 2011; Oeseburg et al., 2011). The present results suggest that 
these higher prevalence rates may in fact be due to these comorbid diagnoses, rather than to ID itself. 
Further studies, which take these variables into account, need to be undertaken in order to disentangle 
the relationship between ID, other associated diagnoses, and psychological disorders. 
Second, only four studies (Baker et al., 2010; Emerson & Hatton, 2007; Green et al., 2015; 
Hardan & Sahl, 1997) compared the risk of anxiety/depressive disorders between youth with ID and TD 
youth. Therefore, it is unknown whether youth with ID were at greater risk of being diagnosed as having 
anxiety or depressive disorders than TD youth. Clearly, this is an important issue to consider in future 
studies.  
Third, the time frame used in the diagnosis of anxiety and depressive disorders (i.e., current or 
lifetime) was reported in very few studies. Therefore, the role of this critically important factor in the 
prevalence estimates of anxiety or depressive disorders is unclear and should be more thoroughly 
investigated in future studies. 
Fourth, only a few of the reviewed studies have examined specific subtypes of anxiety or 
depressive disorders among youth with ID. Additionally, none of the reviewed studies used diagnostic 
criteria adapted to individuals with ID. In future investigations, it would be interesting to determine the 
prevalence of anxiety or depressive disorders when using ID adapted diagnostic criteria compared to 
classic DSM or ICD criteria.  
Finally, only five of the reviewed studies were population-based (Dekker & Koot, 2003; Emerson 
& Hatton, 2007; Gillberg et al., 1986; Jacobson, 1990; Rojahn et al., 1993). Therefore, serious concerns 
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of the reported prevalence estimates. 
5. Conclusion 
The present meta-analysis reveals that prevalence of anxiety and depressive disorders among 
youth with ID are generally similar to those found in TD children and adolescents. Additionally, findings 
reveal that diagnostic method (diagnostic criteria, types of informant) and youth’s ID level may affect the 
likelihood of being diagnosed with an anxiety or depressive disorder. Significantly, the results of this 
meta-analysis highlight the potential inadequacy of current diagnostic criteria and diagnostic procedures 
to sufficiently recognize anxiety and depressive disorders in youth with ID. The comparison of 
psychological risk between youth with ID and TD youth still remains an understudied research area, and 
one hampered by diagnostic challenges with this population. Similarly, greater efforts are needed to 
ensure that clinicians optimize their capacity to appropriately diagnose comorbid anxiety and depression 
in youth with ID, and international psychological policy and practice need to be developed to meet this 
challenge. In sum, findings from this systematic review and meta-analysis will help to increase awareness 
among clinicians, service agencies, and policy makers about the nature of psychological disorders 
experienced by this vulnerable population. More importantly, these results should help key stakeholders 
to tailor resources to support youth with ID in the management of their anxiety and depressive 
disorders, and to better address fundamental issues of diagnosis that underpin and direct service 
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1 Other reviews (e.g., Borthwick-Duffy, 1994; Buckles, Luckasson, & Keefe, 2013; Hemmings, Deb, 
Chaplin, Hardy, & Mukherjee, 2013; Yoo, Valdovinos, & Schroeder, 2012) focused on the prevalence of 
psychopathology, psychiatric disorders, or mental health disorders among people with ID, but they did 
not synthetize their results separately for children-adolescents versus adults. 
2 In studies focusing specifically on participants with ID, those including participants with borderline ID 
were considered because these participants also face “substantially elevated cognitive and morbidity 
risks as well as problems in adaptive behavior” (Oeseburg et al., 2011, p. 60). 
3 This category includes studies using a general (or unspecified) measure of anxiety disorder or providing 
an overall prevalence rate for combined subtypes of anxiety disorders. 
4 This category includes studies using a general (or unspecified) measure of depressive disorder or 
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manual search  




Records identified by searching: 
Academic Search Complete, CINAHL Plus with Full-
Text, Education Source, ERIC, Medline with Full-Text, 
PsycARTICLES (including PsycINFO), Psychology and 
Behavioral Sciences Collection, Scopus, SocINDEX  
Records after duplicates removed 
(n = 7,786) 
Full text articles assessed for eligibility 
(n = 113) 
Records screened on basis of titles and abstracts 
(n = 7,786) 
Articles excluded based on  
titles and abstracts  
(n = 7,673) 
Full text articles excluded (n = 92) 
Reasons:  
- Data on anxiety/depression were not 
separated (n = 6) 
- Mixed adolescents-adults sample (n = 7) 
- No diagnosis of anxiety/depression (n= 10) 
- No measure of prevalence (n= 30) 
- No measure of anxiety or 
depression (n = 13) 
Anxiety 
articles  
(n = 6) 
Depression 
articles  
(n = 2) 
Articles included in the meta-analysis 
































Figure 1. Results of search based on the PRISMA statement (Liberati et al., 2009) 
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Figure 2. Forest plot of random-effects pooled prevalence estimates of combined subtypes of anxiety 
disorders in (a) all reviewed samples (mixed, children, and adolescents), (b) children samples, and (c) 
adolescent samples 
Note. For the estimation of the overall sample, the prevalence estimates of the children and the 
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Figure 3. Forest plot of random-effects pooled prevalence estimates of combined subtypes of depressive 
disorders in (a) all reviewed samples (mixed, children, and adolescents), and (b) adolescent samples 
Note. For the estimation of the overall sample, the prevalence estimates of the children and the 
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Table 1 
Main Characteristics of the Studies Included in the Meta-Analysis 
Study Country Design Recruitment setting Type of 
samples 

















ID level  Yes/No 
Sample 
size (N) 
Baker et al. (2010) USA Cohort Service agencies CHILD 95a 60 5 NM   Yes 141 
Bradley et al. (2011) Canada CS NM ADOS 72b NM 14-20 NM  No  
Chadwick et al. (2005) UK Cohort Special school CHILD 82c 56 4-11 Severe   No   
Dekker & Koot (2003) 
Netherland
s 
Cohort Special school Mixed 474 62 7-20 Mild-Moderate   No   
Emerson & Hatton (2007) UK CC 
National survey - 
ONS (1999, 2004) 
Mixed 641 66 5-15 NM   Yes 17,774 
Gillberg et al. (1986) Sweden CS Service agencies, schools ADOS 149 62 13-17 Mild-Severe   No   
Gothelf et al. (2008) Israel CS Special school ADOS 87d 53 12-21 Mild-Moderate   No   
Green et al. (2015) USA Cohort Service agencies CHILD 74a 61 5 Borderline-Moderate   Yes 116 
Hardan & Sahl (1997) USA CC 
Service agencies, 
community, school 
ixed 170e NM 3-19 Borderline-Profound   Yes 63 
Hassiotis & Turk (2012) UK CS Service agencies ADOS 75 64 12-19 Mild-Profound   No   
Jacobson (1990) USA CS Information system  Mixed 9,876 59 0-21 Mild-Profound   No   
Khess et al. (1998) India CS Child psychiatric unit Mixed 60 68 NM Mild-Profound   No   
Koskentausta et al. (2002) Finland CS 
Rehabilitation center, 
hospitals, special schools 
Mixed 155 59 6-13 Mild-Profound   No   
Lakhan (2013) India CS Service agencies Mixed 262f NM 3-18 Borderline-Profound   No   
Manor-Binyamini (2010) Israel CS Special school ADOS 30 70 12-21 Mild-Moderate   No   
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Note. ADOS = adolescent sample; CC = case control; CHILD = children sample; CS = cross-sectional; N = number; NM = not mentioned; TD = typically developing; UK = United Kingdom; USA = United States of 
America. 
a
The data are those from age 5 only, and the participants with a borderline intellectual disability were included. 
b
This sample includes youth with intellectual disabilities and youth with intellectual 
disabilities and autism; 
c
The data are those from the initial study. 
d
Only the current prevalence's data have been used. 
e
The participants with a borderline and an unspecified intellectual disability were 
included in the sample. 
f
The participants with a borderline intellectual disability were included in the sample. 
g
The participants with a borderline intellectual disability were not included in the sample 
because they were reported together with those without an intellectual disability. 
h
This sample only comprised children with intellectual disabilities without psychiatric disorders. 
i
The data from the New 
York State sample were not included because of the probable overlap with Jacobson's (1990) sample.  
Philipps & Williams (1975) USA CS Psychiatric clinic Mixed 62h 61 0-18 Borderline-Severe   No   
Reiss (1982) USA CS Service agencies Mixed 33 70 6-20 Mild-Profound   No   
Rojahn et al. (1993) USA CS Service agencies 
CHILD, 
ADOS 
43,738i NM 0-20 Mild-Profound   No   
Stromme & Diseth (2000) Norway CS Referred to the study Mixed 178 58 8-13 Mild-Severe   No   











TAnxiety, Depression, and Intellectual Disabilities        41 Table 2 
Diagnostic Information and Types of Anxiety and Depressive Disorders of the Studies Included in the Meta-Analysis 
Study 
Diagnostic information  
Types of anxiety disorders Types of depressive disorders 
Informant Method Criteria  
Baker et al. (2010) P Interview-S (DISC-IV) DSM-IV-TR   Not included MDD, DD 
Bradley et al. (2011) P Interview-S (SAPPA) ICD-10   GAD Not examined 
Chadwick et al. (2005) P Medical records NM   Combineda Not examined 
Dekker & Koot (2003) C, P Interview-S (DISC-IV) DSM-IV   
Combineda, AGO, GAD, OCD, PDWA, 
PDWIA, PTSD, SAD, SP, SPHOBIA 
MDD, DD 
Emerson & Hatton (2007) C, Y, T Multiple assessments ICD-10   
Combineda, AGO, GAD, OCD, PD, PTSD, 
SAD, SP, SPHOBIA 
Combinedb 
Gillberg et al. (1986) P, Y Multiple assessments DSM-III   Combinedc Combinedd 
Gothelf et al. (2008) P Interview-S (K-SADS-PL) DSM-IV-TR   
Combineda, GAD, OCD, PD, PTSD, SAD, 
SP, SPHOBIA 
MDD, DD 
Green et al. (2015) P Interview-S (DISC-IV) DSM-IV   Combineda, GAD, SAD, SP Not examined 
Hardan & Sahl (1997) NM Medical records DSM-III-R   Combinede, OCD, PTSD Combinedf 
Hassiotis & Turk (2012) Y Interview-SM ICD-10   Combineda, SP Combinedb 
Jacobson (1990) NM Medical records DSM-II   Combinedg Combinedh 
Khess et al. (1998) NM Multiple assessments ICD-10   Not examined Combinedi 
Koskentausta et al. (2002) NM Medical records ICD-10   Combinedj MDD 











TAnxiety, Depression, and Intellectual Disabilities        42 Manor-Binyamini (2010) P Interview-S (K-SADS-PL) DSM-IV-TR   Combineda, OCD, SPHOBIA Not examined 
Myers (1987) P Multiple assessments DSM-III   Combinedm Combinedn 
Philipps & Williams (1975) NM Medical records DSM-II   Combinedo Not examined 
Reiss (1982) C, P, Y Multiple assessments NM   Combinedp Combinedi 
Rojahn et al. (1993) NM Medical records DSM-III-R   Combineda Combinedq 
Stromme & Diseth (2000) P, Y Multiple assessments ICD-10   Combinedr Not examined 
Temtek et al. (2015) NM Medical records DSM-IV-TR   Combineda Not examined 
Note. AGO = agoraphobia without panic disorder; C = caregiver; DD = dysthymic disorder; DISC-IV = Diagnostic Interview Schedule for Children – 4th version; DSM-II = diagnostic and statistical manual of mental 
disorders – 2nd edition; DSM-III = diagnostic and statistical manual of mental disorders – 3rd edition; DSM-III-R = diagnostic and statistical manual of mental disorders – revised 3rd edition; DSM-IV = diagnostic and 
statistical manual of mental disorders – 4th edition; DSM-IV-TR = diagnostic and statistical manual of mental disorders – text revision of the 4th edition; GAD = generalized anxiety disorder; ICD-10 = international 
statistical classification of diseases and related health problems – 10th revision; Interview-S  = structured interview; Interview-SM = semi-structured interview; K-SADS-PL = Schedule for Affective Disorders and 
Schizophrenia for School-Aged Children, Present and Lifetime; MDD = major depressive disorder; NM = not mentioned; OCD = obsessive-compulsive disorder; P = parents; PD = panic disorder; PDWA = panic disorder 
without agoraphobia; PDWIA = panic disorder with agoraphobia; PTSD = posttraumatic stress disorder; SAD = separation anxiety disorder; SAPPA = Schedule for the Assessment of Psychiatric Problems associated 
with Autism (and other developmental disorders); SP = social phobia; SPHOBIA = specific phobia; T = teacher; Y = youth. These data were not included because of the probable overlap with the Green et al.'s (2015) 
sample. Given that the nature of phobia was not specified these data were not included. aanxiety disorder. bDepressive disorder. cEmotional disorder (anxiety and fear without loss of reality-sense were the most 
incapacitating symptoms). dDepressive syndrome. eOveranxious disorder, separation anxiety disorder, anxiety disorder, not otherwise specified, phobias, and panic disorder. fDepressive major, depressive disorder, 
recurrent, depressive disorder, not otherwise specified, and dysthymia. gNeurosis (anxiety and phobic disorders). hNonpsychotic organic brain syndromes. iDepression. jEmotional disorders with onset specific to 
childhood. kAnxiety, obsessive compulsive disorder. lDepression. mSeparation anxiety disorder, overanxious, obsessive compulsive disorder. nDepression, major affective disorder. oNeurotic traits (phobias, obsessive-
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Random effects models   Tests for heterogeneity   Publication bias 
Prevalence 95% CI 
Z-
value 








DT-TF Prevalence 95% CI 
All Combined 18 5.4% (2.5% to 11.5%) -6.82 <.001 
 
1110.2 17 <.001 98 
 
.11 .34 1 missing 4.7% (2.1% to 10%) 
AGO 2 0.6% (0.1% to 3.6%) -5.51 <.001   3.7 1 .05 73   NA NA NA 
   GAD 5 2.2% (0.5% to 9.1%) -4.95 <.001 
 
39.7 4 <.001 90 
 
.40 .21 No missing 
   OCD 6 2.4% (0.8% to 7.2%) -6.43 <.001  40.0 5 <.001 87   .13 .15 No missing 
   PD 2 0.3% (0.1% to 1.2%) -7.89 <.001   0.4 1 .53 0   NA NA NA 
   PDWA 1 0.4% (0.1% to 1.6%) -7.58 <.001   0 0 1 0   NA NA NA 
   PDWIA 1 0.2% (0.03% to 1.5%) -6.04 <.001   0 0 1 0   NA NA NA 
   PTSD 4 1.1% (0.3% to 3.7%) -7.20 <.001   10.4 3 .02 71   .50 .21 No missing 
   SAD 4 5.0% (1.8% to 13.3%) -5.36 <.001   35.6 3 <.001 92   .37 .38 No missing 
   SP 5 2.7% (1.2% to 5.8%) -8.75 <.001   15.7 4 .003 75   .40 .48 No missing 
   SPHOBIA 4 11.5% (4.0% to 28.9%) -3.52 <.001   63.1 3 <.001 95   .50 .33 1 missing 10.2% (4.1% to 23.2%) 
Children Combined 3 1.2% (0.02% to 49.1%) -1.98 .048   224.1 2 <.001 99   .50 .39 2 missing 0.1% (0.001% to 5.5%) 
AGO - - - - - -   - - - -   - - - 
   GAD 1 0.7% (0.04% to 9.8%) -3.53 <.001   0 0 1 0   NA NA NA 
   OCD - - - - - -   - - - -   - - - 
   PD - - - - - -   - - - -   - - - 
   PDWA - - - - - -   - - - -   - - - 
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   PTSD - - - - - -   - - - -   - - - 
   SAD 1 17.6% (10.5% to 21.8%) -5.06 <.001   0 0 1 0   NA NA NA 
   SP 1 2.7% (0.7% to 10.2%) -5.00 <.001   0 0 1 0   NA NA NA 
   SPHOBIA - - - - - -   - - - -   - - - 
   Adolescents Combined 5 7.9% (0.6% to 54.6%) -1.82 .068   499.7 4 <.001 99   .50 .12 3 missing 0.5% (0.03% to 7.8%) 
AGO - - - - - -   - - - -   - - - 
   GAD 2 8.7% (2.4% to 27.1%) -3.39 <.001   4.4 1 .03 78 
 
NA NA NA 
   OCD 2 12.0% (7.2% to 19.2%) -7.00 <.001   0.1 1 .79 0   NA NA NA 
   PD 1 0.6% (0.04% to 8.4%) -3.64 <.001   0 0 1 0   NA NA NA 
   PDWA - - - - - -   - - - -   - - - 
   PDWIA - - - - - -   - - - -   - - - 
   PTSD 1 3.4% (1.1% to 10.2%) -5.67 <.001   0 0 1 0   NA NA NA 
   SAD 1 5.7% (2.4% to 13.1%) -6.07 <.001   0 0 1 0   NA NA NA 
   SP 2 5.4% (1.9% to 14.6%) -5.11 <.001   2 2 .16 50   NA NA NA 
   SPHOBIA 2 19.8% (11.8% to 31.3%) -4.47 <.001   1.6 1 .21 38   NA NA NA 
   Note. AGO = agoraphobia without panic disorder; B-M test = Begg and Mazumdar rank correlation test; DT-FT = Duval and Tweedie's trim and fill; Egger-T = Egger's test of the intercept; 
GAD = generalized anxiety disorder; OCD = obsessive-compulsive disorder; PD = panic disorder; PDWA = panic disorder without agoraphobia; PDWIA = panic disorder with agoraphobia; 
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Table 4 







Random effects models   Tests for heterogeneity   Publication bias 
Prevalence 95% CI 
Z-
value 






DT-TF Prevalence 95% CI 
All Combined 10 2.8% (1.1% to 6.7%) -7.58 0.00  242.3 9 <.001 96  .24 .31 3 missing 1.6% (0.6% to 3.7%) 
DD 3 3.4% (1.5% to 7.4%) -7.95 <.001 
 
5.2 2 .07 62 
 
.50 .45 No missing 
   MDD 4 2.5% (1.2% to 5.4%) -8.98 <.001 
 
6.8 3 .08 56 
 
.50 .41 No missing 
   Children Combined 1 0.03% (0.02% to 0.06%) -24.00 <.001 0 0 1 0 NA NA NA  
DD 1 2.1% (0.5% to 8.0%) -5.37 <.001 
 
0 0 1 0 
 
NA NA NA 
   MDD 1 3.2% (1.0% to 9.4%) -5.85 <.001 
 
0 0 1 0 
 
NA NA NA 
   Adolescents Combined 3 1.4% (0.4% to 5.1%) -6.31 0.00 14.5 2 <.001 86 .50 .07 2 missing 0.5% (0.2% to 1.6%) 
DD 1 6.9% (3.1% to 14.5%) -6.15 <.001 
 
0 0 1 0 
 
NA NA NA 
   MDD 1 5.7% (2.4% to 13.1%) -6.07 <.001 
 
0 0 1 0 
 
NA NA NA 
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Table 5 
Quality Assessment of the Reviewed Studies 
Studies  






























of the study 
(yes/no) 
Validity and 












Baker et al. (2010)     
 
      
Bradley et al. (2011)            
Chadwick et al. (2005)     
 
      
Dekker & Koot (2003)     
 
      
Emerson & Hatton 
(2007) 
    
 
      
Gillberg et al. (1986)     
 
      
Gothelf et al. (2008)     
 
      
Green et al. (2015)     
 
      
Hardan & Sahl (1997)     
 
      
Hassiotis & Turk (2012)     
 
      
Jacobson (1990)     
 
      
Khess et al. (1998)     
 
      
Koskentausta et al. 
(2002) 
    
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      
Manor-Binyamini (2010)     
 
      
Myers (1987)     
 
      
Philipps & Williams 
(1975) 
    
 
      
Reiss (1982)     
 
      
Rojahn et al. (1993)     
 
      
Stromme & Diseth 
(2000) 
    
 
      
Temtek et al. (2015)     
 
      
Total 6/21 4/21 9/21 1/21 
 
7/21 15/21 11/21 5/21 4/21 2/21 
Note.  = met the criteria;  = did not meet the criteria; Total = number of studies meeting each quality criteria 
